Here are five points:
1. Vertiflex develops minimally invasive interventions for spinal stenosis.
2. Endeavour Vision and H.I.G. BioHealth Partners, both new investors, led the financing round.
3. Existing investors, New Enterprise Associates, Thomas, McNerney & Partners and Alta Partners also led the round.
4. Vertiflex will use most of the funds for the U.S. commercial expansion of the Superion Indirect Decompression System, which is a MIS implant for treating lumbar spinal stenosis.
5. The Superion device, labeled an American Medical Association Current Procedural Terminology Category I code, is designed to decrease pressure on impacted nerves.
More articles on MIS:
Inspired Spine hosts surgeon training for MIS procedures in cadaver lab: 5 highlights
Vertos Medical receives CMS broad coverage approval for mild procedure: 5 key notes
5 notes on bilateral percutaneous fixation in MIS spine surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
